Phase 1 Sleep Disorders Trial, Recruiting NCT03860233 Sponsor: Vivek Jain Condition: Sleep Disorders
Back to Sleep Disorders

Phase 1 Sleep Disorders Trial, Recruiting

NCT03860233
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older, of any gender

Who may not be able to join:

  • People who are not willing or able to use a CPAP machine (a breathing device worn during sleep) to treat obstructive sleep apnea
  • People who have other sleep disorders in addition to the condition being studied
  • People who are pregnant or breastfeeding
  • Women of childbearing age who are not willing or able to use an accepted form of contraception for the full duration of the study
  • People who are currently in prison or otherwise involuntarily held in a detention facility
  • People who are being held or treated against their will due to a psychiatric condition or an infectious disease
  • People who are not able to give informed consent, for example due to a language barrier or another reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Vivek Jain, MD, George Washington University

Phone: 202-741-2237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Vivek Jain
Registry
ClinicalTrials.gov
Start date
4 March 2019
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Use of oxytocin will change pressure required to keep open airway during auto-CPAP use

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov